Risk factors for the recurrence of early hepatocellular carcinoma treated by percutaneous radiofrequency ablation with a multiple-electrode switching system: a multicenter prospective study

References

• Wallace MC, Preen DB, Short MW, et al. Hepatocellular carcinoma in Australia 1982–2014: increasing incidence and improving survival. Liver Int. 2019;39(3):522–530.
   PubMed Web of Science ®Google Scholar
• Lencioni R, Crocetti L. Local-regional treatment of hepatocellular carcinoma. Radiology. 2012;262(1):43–58.
   PubMed Web of Science ®Google Scholar
• Feng K, Yan J, Li X, et al. A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma. J Hepatol. 2012;57(4):794–802.
   PubMed Web of Science ®Google Scholar
• Feng K, Ma K, Liu Q, et al. Randomized clinical trial of splenic radiofrequency ablation versus splenectomy for severe hypersplenism. Br J Surg. 2011;98(3):354–361.
   PubMed Web of Science ®Google Scholar
• Nishikawa H, Inuzuka T, Takeda H, et al. Percutaneous radiofrequency ablation therapy for hepatocellular carcinoma: a proposed new grading system for the ablative margin and prediction of local tumor progression and its validation. J Gastroenterol. 2011;46(12):1418–1426.
   PubMed Web of Science ®Google Scholar
• Nishikawa H, Kimura T, Kita R, et al. Radiofrequency ablation for hepatocellular carcinoma. International journal of hyperthermia: the official journal of European society for hyperthermic oncology. Int J Hyperthermia. 2013;29(6):558–568.
   PubMed Web of Science ®Google Scholar
• Jiang J, Chen S, Li K, et al. Targeting autophagy enhances heat stress-induced apoptosis via the ATP-AMPK-mTOR axis for hepatocellular carcinoma. International journal of hyperthermia: the official journal of European society for hyperthermic oncology. Int J Hyperthermia. 2019;36(1):499–510.
   PubMed Web of Science ®Google Scholar
• Lupo L, Panzera P, Giannelli G, et al. Single hepatocellular carcinoma ranging from 3 to 5 cm: radiofrequency ablation or resection? HPB (Oxford). 2007;9(6):429–434.
   PubMedGoogle Scholar
• Medhat E, Abdel Aziz A, Nabeel M, et al. Value of microwave ablation in treatment of large lesions of hepatocellular carcinoma. J Dig Dis. 2015;16(8):456–463.
   PubMed Web of Science ®Google Scholar
• Woo S, Lee JM, Yoon JH, et al. Small- and medium-sized hepatocellular carcinomas: monopolar radiofrequency ablation with a Multiple-Electrode switching System-Mid-term results. Radiology. 2013;268(2):589–600.
   PubMed Web of Science ®Google Scholar
• Ryu T, Takami Y, Wada Y, et al. Actual 10-year survival after surgical microwave ablation for hepatocellular carcinoma: a single-center experience in Japan. Ann Surg Oncol. 2019;26(12):4126–4133.
   PubMed Web of Science ®Google Scholar
• Zhang W, Luo E, Gan J, et al. Long-term survival of hepatocellular carcinoma after percutaneous radiofrequency ablation guided by ultrasound. World J Surg Oncol. 2017;15(1):122.
   PubMed Web of Science ®Google Scholar
• European Association for the Study of the Liver. Electronic address EEE, European Association for the Study of the LEASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2018;69(1):182–236.
   PubMed Web of Science ®Google Scholar
• Heimbach JK, Kulik LM, Finn RS, et al. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology. 2018;67(1):358–380.
   PubMed Web of Science ®Google Scholar
• N'Kontchou G, Mahamoudi A, Aout M, et al. Radiofrequency ablation of hepatocellular carcinoma: long-term results and prognostic factors in 235 Western patients with cirrhosis. Hepatology. 2009;50(5):1475–1483.
   PubMed Web of Science ®Google Scholar
• Lee DH, Lee JM, Kang TW, et al. Clinical outcomes of radiofrequency ablation for early hypovascular HCC: a multicenter retrospective study. Radiology. 2018;286(1):338–349.
   PubMed Web of Science ®Google Scholar
• Sartori S, Tombesi P, Macario F, et al. Subcapsular liver tumors treated with percutaneous radiofrequency ablation: a prospective comparison with nonsubcapsular liver tumors for safety and effectiveness. Radiology. 2008;248(2):670–679.
   PubMed Web of Science ®Google Scholar
• Laeseke PF, Sampson LA, Haemmerich D, et al. Multiple-electrode radiofrequency ablation creates confluent areas of necrosis: in vivo porcine liver results. Radiology. 2006;241(1):116–124.
   PubMed Web of Science ®Google Scholar
• Wang-Yuan Z, Jiang-Zheng Z, Lu YD, et al. Clinical efficacy of metronomic chemotherapy after cool-tip radiofrequency ablation in the treatment of hepatocellular carcinoma. International journal of hyperthermia: the official journal of European society for hyperthermic oncology. Int J Hyperthermia. 2016;32(2):193–198.
   PubMed Web of Science ®Google Scholar
• Ahmed M, Solbiati L, Brace CL, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria-a 10-year update. Radiology. 2014;273(1):241–260.
   PubMed Web of Science ®Google Scholar
• Cabassa P, Donato F, Simeone F, et al. Radiofrequency ablation of hepatocellular carcinoma: long-term experience with expandable needle electrodes. AJR Am J Roentgenol. 2006;186(5):S316–S321.
   PubMed Web of Science ®Google Scholar
• Livraghi T, Goldberg SN, Lazzaroni S, et al. Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions. Radiology. 2000;214(3):761–768.
   PubMed Web of Science ®Google Scholar
• Weisbrod AJ, Atwell TD, Callstrom MR, et al. Percutaneous radiofrequency ablation with a multiple-electrode switching-generator system. J. Vasc. Interv. Radiol. 2007;18(12):1528–1532.
   PubMed Web of Science ®Google Scholar
• Laeseke PF, Frey TM, Brace CL, et al. Multiple-electrode radiofrequency ablation of hepatic malignancies: initial clinical experience. AJR Am J Roentgenol. 2007;188(6):1485–1494.
   PubMed Web of Science ®Google Scholar
• Shiina S, Tateishi R, Arano T, et al. Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors. Am J Gastroenterol. 2012;107(4):569–577.
   PubMed Web of Science ®Google Scholar
• Liang P, Yu J, Yu XL, et al. Percutaneous cooled-tip microwave ablation under ultrasound guidance for primary liver cancer: a multicentre analysis of 1363 treatment-naive lesions in 1007 patients in China. Gut. 2012;61(7):1100–1101.
   PubMed Web of Science ®Google Scholar
• Okuda K. Hepatocellular carcinoma: recent progress. Hepatology. 1992;15(5):948–963.
   PubMed Web of Science ®Google Scholar
• Okuwaki Y, Nakazawa T, Shibuya A, et al. Intrahepatic distant recurrence after radiofrequency ablation for a single small hepatocellular carcinoma: risk factors and patterns. J Gastroenterol. 2008;43(1):71–78.
   PubMed Web of Science ®Google Scholar
• Ng KK, Poon RT, Lo CM, et al. Analysis of recurrence pattern and its influence on survival outcome after radiofrequency ablation of hepatocellular carcinoma. J Gastrointest Surg. 2008;12(1):183–191.
   PubMed Web of Science ®Google Scholar
• Kim JM, Kwon CH, Joh JW, et al. The effect of alkaline phosphatase and intrahepatic metastases in large hepatocellular carcinoma. World J Surg Oncol. 2013;11:40.
   PubMed Web of Science ®Google Scholar
• Lencioni R, Cioni D, Crocetti L, et al. Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology. 2005;234(3):961–967.
   PubMed Web of Science ®Google Scholar
• Choi D, Lim HK, Rhim H, et al. Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: long-term results and prognostic factors in a large single-institution series. Eur Radiol. 2007;17(3):684–692.
   PubMed Web of Science ®Google Scholar
• Kim YS, Lim HK, Rhim H, et al. Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma: analysis of prognostic factors. J Hepatol. 2013;58(1):89–97.
   PubMed Web of Science ®Google Scholar
• Takahashi S, Kudo M, Chung H, et al. Outcomes of nontransplant potentially curative therapy for early-stage hepatocellular carcinoma in child-pugh stage a cirrhosis is comparable with liver transplantation. Dig Dis. 2007;25(4):303–309.
   PubMed Web of Science ®Google Scholar
• Vouche M, Kulik L, Atassi R, et al. Radiological-pathological analysis of WHO, RECIST, EASL, mRECIST and DWI: imaging analysis from a prospective randomized trial of Y90 +/- Sorafenib. Hepatology. 2013;58(5):1655–1666.
   PubMed Web of Science ®Google Scholar
• Rhim H. Recent advance of local ablation for hepatocellular carcinoma. J Korean Med Assoc. 2013;56(11):964–971.
   Web of Science ®Google Scholar
• Takuma Y, Takabatake H, Morimoto Y, et al. Comparison of combined transcatheter arterial chemoembolization and radiofrequency ablation with surgical resection by using propensity score matching in patients with hepatocellular carcinoma within Milan criteria. Radiology. 2013;269(3):927–937.
   PubMed Web of Science ®Google Scholar
• Saviano A, Iezzi R, Giuliante F, Hepato CSG, et al. Liver resection versus radiofrequency ablation plus transcatheter arterial chemoembolization in cirrhotic patients with solitary large hepatocellular Carcinoma. J Vasc Interv Radiol. 2017;28(11):1512–1519.
   PubMed Web of Science ®Google Scholar
• Kim W, Cho SK, Shin SW, et al. Combination therapy of transarterial chemoembolization (TACE) and radiofrequency ablation (RFA) for small hepatocellular carcinoma: comparison with TACE or RFA monotherapy. Abdom Radiol (NY). 2019;44(6):2283–2292.
   PubMed Web of Science ®Google Scholar
• Lee HJ, Kim JW, Hur YH, et al. Conventional chemoembolization plus radiofrequency ablation versus surgical resection for single, Medium-Sized hepatocellular carcinoma: propensity-score matching analysis. J Vasc Interv Radiol. 2019;30(3):284–292. e281.
   PubMed Web of Science ®Google Scholar
• Kagawa T, Koizumi J, Kojima S, et al. Transcatheter arterial chemoembolization plus radiofrequency ablation therapy for early stage hepatocellular carcinoma: comparison with surgical resection. Cancer. 2010;116(15):3638–3644.
   PubMed Web of Science ®Google Scholar
• Bholee AK, Peng K, Zhou Z, et al. Radiofrequency ablation combined with transarterial chemoembolization versus hepatectomy for patients with hepatocellular carcinoma within Milan criteria: a retrospective case-control study. Clin Transl Oncol. 2017;19(7):844–852.
   PubMed Web of Science ®Google Scholar
• Facciorusso A, Di Maso M, Muscatiello N. Microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma: a systematic review and Meta-analysis. Int J Hyperthermia. 2016;32(3):339–344.
   PubMed Web of Science ®Google Scholar
• Tan W, Deng Q, Lin S, et al. Comparison of microwave ablation and radiofrequency ablation for hepatocellular carcinoma: a systematic review and Meta-analysis. Int J Hyperthermia. 2019;36(1):264–272.
   PubMed Web of Science ®Google Scholar
• Lee DH, Lee MW, Kim PN, et al. Outcome of No-Touch radiofrequency ablation for small hepatocellular carcinoma: a multicenter clinical trial. Radiology. 2021;301(1):229–236.
   PubMed Web of Science ®Google Scholar
• Quirk MT, Pomykala KL, Suh RD. Current readings: percutaneous ablation for pulmonary metastatic disease. Semin Thorac Cardiovasc Surg. 2014;26(3):239–248.
   PubMedGoogle Scholar
• Prud’homme C, Deschamps F, Moulin B, et al. Image-guided lung metastasis ablation: a literature review. International journal of hyperthermia: the official journal of European society for hyperthermic oncology. North Am Hyperthermia Group. 2019;36(2):37–45.
   PubMed Web of Science ®Google Scholar
• Choi D, Lim HK, Kim MJ, et al. Recurrent hepatocellular carcinoma: percutaneous radiofrequency ablation after hepatectomy. Radiology. 2004;230(1):135–141.
   PubMed Web of Science ®Google Scholar
• Buscarini L, Buscarini E, Di Stasi M, et al. Percutaneous radiofrequency ablation of small hepatocellular carcinoma: long-term results. Eur Radiol. 2001;11(6):914–921.
   PubMed Web of Science ®Google Scholar
• Tateishi R, Shiina S, Teratani T, et al. Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer. 2005;103(6):1201–1209.
   PubMed Web of Science ®Google Scholar
• Cho YK, Kim JK. Sustained complete response and low complication rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis. Hepatology. 2008;47(5):1791–1791.
   PubMed Web of Science ®Google Scholar
• Nomi T, Fuks D, Govindasamy M, et al. Risk factors for complications after laparoscopic major hepatectomy. Br J Surg. 2015;102(3):254–260.
   PubMed Web of Science ®Google Scholar
• Ratti F, Cipriani F, Ariotti R, et al. Laparoscopic major hepatectomies: current trends and indications. A comparison with the open technique. Updates Surg. 2015;67(2):157–167.
   PubMedGoogle Scholar
• Komatsu S, Brustia R, Goumard C, et al. Laparoscopic versus open major hepatectomy for hepatocellular carcinoma: a matched pair analysis. Surg Endosc. 2016;30(5):1965–1974.
   PubMed Web of Science ®Google Scholar
• Francica G, Altiero M, Laccetti E, et al. Long-term follow-up of unresectable medium-large hepatocellular carcinoma nodules treated with radiofrequency ablation using a multiple-electrode switching system. BJR. 2018;92(1093):20180625.
   Google Scholar